Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SirtAct (CAY-10591)

Inh 839699-72-8 2-Amino-N-cyclopentyl-1-(3-methoxypropyl)-1H-pyrrolo[2,3-b]quinoxaline-3-carboxamide
N° du produit ABIN7233290

Aperçu rapide pour SirtAct (CAY-10591) (ABIN7233290)

Application

Inhibition (Inh)

Chemical Name

2-Amino-N-cyclopentyl-1-(3-methoxypropyl)-1H-pyrrolo[2,3-b]quinoxaline-3-carboxamide
  • Fonction

    SIRT1 activator

    Attributs du produit

    Sirt1 activator (233 % at 10 μM)1 Suppresses TNFα release from THP-1 cells and stimulates adipogenesis in 3T3L1 cells. SIRT1 stimulation by SirtAct leads to decreased tissue factor mediated thrombogenicity in mice. Inhibits NFκB activation and reduces inflammatory cytokine production in lamina propria mononuclear cells from IBD patients. Prevents and cures experimental colitis in a mouse model.

    Pureté

    >98 %

    Formula

    C20H25N5O2

    Solubility

    Soluble in DMSO (up to 50 mg/ml) or in Ethanol (up to 20 mg/ml).
  • Restrictions

    For Research Use only
  • Format

    Powder

    Stock

    -20 °C
  • Sujet

    CAY10591,Posttranslational modification,Epigenetics,Chromatin,Protein deacetylase,Diabetes,Inflammation,Cytokine,NFkappaB

    Poids moléculaire

    367.46

    Numéro CAS

    839699-72-8
Vous êtes ici:
Chat with us!